Skip to main content

letter

. 1995 Jul;72(1):250. doi: 10.1038/bjc.1995.312

New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.

R J Mairs, M R Zalutsky

PMCID: PMC2034123 PMID: 7599061

250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Andrews P. L., Rapeport W. G., Sanger G. J. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci. 1988 Sep;9(9):334–341. doi: 10.1016/0165-6147(88)90106-x. [DOI] [PubMed] [Google Scholar]
Fredrikson M., Hursti T. J., Steineck G., Fürst C. J., Börjesson S., Peterson C. Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. Br J Cancer. 1994 Oct;70(4):642–645. doi: 10.1038/bjc.1994.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
Vaidyanathan G., Zalutsky M. R. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine. Appl Radiat Isot. 1993 Mar;44(3):621–628. doi: 10.1016/0969-8043(93)90179-e. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES